Neural antibodies can specifically label and recognize molecules on nerve cells, enabling a more comprehensive understanding and study of the biological properties, functions, and mechanisms of nerve cells in neurodegenerative diseases.
Covering iPSC neural cells, brain organoids, and microelectrode array services, our tools support neural development, disease modeling, and drug screening with high quality and reliable performance to meet diverse research needs.
Number of Launched Drugs:0 Number of Drugs in Clinical Trials:5 Lastest Research Phase:Phase 3 Clinical
Product Inquiry
* We couldn't find what you're looking for. You can let us help by filling the form below. Our
tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information
will be kept strictly confidential.
Synonym Name
IFNB1,Interferon beta,IFN-beta,IFB,IFNB
Background
Human type I interferons (IFNs) are a large subgroup of interferon proteins that help regulate the activity of the immune system. Interferons bind to interferon receptors. All type I IFNs bind to a specific cell surface receptor complex known as the IFN-¦Á receptor (IFNAR) that consists of IFNAR1 and IFNAR2 chains. The IFN-¦Â proteins are produced in large quantities by fibroblasts. They have antiviral activity that is involved mainly in innate immune response. Two types of IFN-¦Â have been described, IFN-¦Â1 (IFNB1) and IFN-¦Â3 (IFNB3) (a gene designated IFN-¦Â2 is actually IL-6). IFN-¦Â1 is used as a treatment for multiple sclerosis as it reduces the relapse rate. Furthermore, IFN-¦Â1 can bind to a IFNAR1-IFNAR2 heterodimeric receptor, and can also function with IFNAR1 alone and independently of Jak-STAT pathways.